The prognostic impact of these markers on survival for patients with HNSCC who were treated with postoperative radiation therapy could not be assessed because only part of patients were examined for p16, Ki-67, and p53 status in this study. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.